Oral Plaque from Type 2 Diabetic Patients Reduces the Clonogenic Capacity of Dental Pulp-Derived Mesenchymal Stem Cells

<div>The graphs display the number of clones (CFU) generated from two distinct primary lines (55P and 56P) derived from subcutaneous adipose tissue and stimulated with ctl and T2D oral plaque, highlighting that there is no significant difference between the treatments. The number of CFU was normalized to the amount of oral plaque (mg).</div>

Stem Cells International

fig2

Figure 2

Figure 2: Oral Plaque from Type 2 Diabetic Patients Reduces the Clonogenic Capacity of Dental Pulp-Derived Mesenchymal Stem Cells 